Anthropic Ships Sonnet 5 With Agentic Safety and Pricing Details
1 July 20265 min read
Medicine
WHO Publishes Updated Framework for AI Governance in Health Systems
The World Health Organization has released guidance for governments and health authorities on establishing governance structures for AI in healthcare, covering procurement, evaluation, post-deployment monitoring and equity considerations.
Illustrative image. Cedar S. Insights uses editorial stock photography; images do not depict specific events described in articles.
The World Health Organization has published an updated framework for AI governance in health systems, providing guidance for governments, ministries of health and health authorities on how to manage the adoption of AI technologies in clinical and public health settings.
The framework covers the full lifecycle of AI in health: from procurement and pre-deployment evaluation through to post-market surveillance, incident reporting and decommissioning. It emphasises that governance structures must be established before AI tools are deployed, not retrofitted after problems emerge.
A significant portion of the guidance addresses equity. The WHO notes that AI systems trained predominantly on data from high-income countries may perform less well in lower-income settings, and that health systems with less digital infrastructure face particular challenges in evaluating and monitoring AI tools.
The framework also addresses the role of patients and communities in AI governance, arguing that affected populations should have meaningful input into decisions about which AI tools are used in their care and how those tools are evaluated.
The WHO guidance is non-binding. Its practical influence depends on whether national health authorities incorporate its recommendations into their own regulatory and procurement frameworks.
Why It Matters
Most AI governance frameworks for healthcare have been developed in high-income countries with established regulatory agencies. The WHO guidance is significant because it addresses the global dimension: the majority of the world's population receives healthcare in settings that lack the regulatory infrastructure of the FDA or EMA. How AI governance develops in lower-income health systems will shape whether AI in healthcare reduces or widens global health inequalities.
Primary Sources
Our sourcing: Cedar S. Insights provides source-led editorial analysis. Reported company, institutional and regulatory claims are attributed to their original sources unless stated otherwise.
Corrections: If a material factual error is identified, Cedar S. Insights will update the relevant article and preserve the distinction between the corrected statement and supporting evidence.
Topics
WHOAI GovernanceHealthcare AIGlobal HealthRegulation